Description: Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.
Home Page: www.achievelifesciences.com
1040 West Georgia Street
Vancouver,
BC
V6E 4H1
Canada
Phone:
604-210-2217
Officers
| Name | Title |
|---|---|
| Mr. Thomas B. King M.B.A. | Executive Chairman |
| Dr. Richard A. B. Stewart | CEO & Executive Director |
| Dr. Cindy Jacobs M.D., Ph.D. | President, Chief Medical Officer & Director |
| Mr. Jerry Wan | Principal Accounting Officer |
| Dr. Anthony Clarke Ph.D. | Chief Scientific Officer |
| Ms. Jaime Xinos | Chief Commercial Officer |
| Dr. Mark L. Rubinstein | Head of Medical Affairs |
| Mr. Craig Donnelly | Executive Vice President of CMC & Regulatory CMC |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Biotechnology |
| GIC Sub-Industry: | Biotechnology |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 4.8378 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 22 |